This is not the most recent version of the article. View current version (30 APR 2014)

Intervention Review

Single versus combination intravenous antibiotic therapy for people with cystic fibrosis

  1. Heather E Elphick1,*,
  2. Anton A Tan2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 20 APR 2005

Assessed as up-to-date: 3 NOV 2011

DOI: 10.1002/14651858.CD002007.pub2


How to Cite

Elphick HE, Tan AA. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002007. DOI: 10.1002/14651858.CD002007.pub2.

Author Information

  1. 1

    Sheffield Children's Hospital, Respiratory Unit, Sheffield, UK

  2. 2

    Booth Hall Children's Hospital, Medical Directorate, Manchester, UK

*Heather E Elphick, Respiratory Unit, Sheffield Children's Hospital, Western Bank, Sheffield, S10 2TH, UK. Heather.Elphick@sch.nhs.uk. H.Elphick@sheffield.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 APR 2005

SEARCH

This is not the most recent version of the article. View current version (30 APR 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mical Paul, Leonard Leibovici, Combination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses, Infectious Disease Clinics of North America, 2009, 23, 2, 277

    CrossRef

  2. 2
    Alexandros P. Grammatikos, Elpis Mantadakis, Matthew E. Falagas, Meta-analyses on Pediatric Infections and Vaccines, Infectious Disease Clinics of North America, 2009, 23, 2, 431

    CrossRef

  3. 3
    A. Espinosa Gimeno, P. Sanmartn Fenollera, J. Valverde Cnovas, Antibi?ticos aminogluc?sidos, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2006, 9, 53, 3475

    CrossRef

  4. 4
    Mical Paul, Simona Grozinsky-Glasberg, Karla Soares-Weiser, Leonard Leibovici, Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis, The Cochrane Library,
  5. You have free access to this content5
    Mical Paul, Adi Lador, Simona Grozinsky-Glasberg, Leonard Leibovici, Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis, The Cochrane Library,
  6. 6
    Mical Paul, Agata Schlesinger, Simona Grozinsky-Glasberg, Karla Soares-Weiser, Leonard Leibovici, Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia, The Cochrane Library,
  7. 7
    Mical Paul, Yaakov Dickstein, Agata Schlesinger, Simona Grozinsky-Glasberg, Karla Soares-Weiser, Leonard Leibovici, Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia, The Cochrane Library,
  8. 8
    Lil Breen, Nivedita Aswani, Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis, The Cochrane Library,
  9. 9
    Lil Breen, Nivedita Aswani, Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis, The Cochrane Library,
  10. 10
    Alan R Smyth, Jayesh Bhatt, Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis, The Cochrane Library,
  11. 11
    Alan R Smyth, Jayesh Bhatt, Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis, The Cochrane Library,
  12. 12
    Alan R Smyth, Jayesh Bhatt, Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis, The Cochrane Library,
  13. 13
    Alan R Smyth, Jayesh Bhatt, Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis, The Cochrane Library,
  14. 14
    Heather E Elphick, Nikki Jahnke, Single versus combination intravenous antibiotic therapy for people with cystic fibrosis, The Cochrane Library,